Ketamine

Generic Name
Ketamine
Brand Names
Ketalar
Drug Type
Small Molecule
Chemical Formula
C13H16ClNO
CAS Number
6740-88-1
Unique Ingredient Identifier
690G0D6V8H
Background

Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic eff...

Indication

Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior oth...

Associated Conditions
-
Associated Therapies
General Anesthesia, Induction and Maintenance of General Anesthesia

Research Study for Major Depressive Disorder: Investigation of Glutamate Medications

First Posted Date
2007-01-05
Last Posted Date
2019-07-31
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
26
Registration Number
NCT00419003
Locations
🇺🇸

Mount Sinai School of Medicine, New York, New York, United States

Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient

First Posted Date
2006-05-24
Last Posted Date
2008-10-08
Lead Sponsor
University Hospital, Clermont-Ferrand
Target Recruit Count
56
Registration Number
NCT00329394
Locations
🇫🇷

Clermont-Ferrand University Hospital, Clermont-Ferrand, France

Effects of Ketamine On Precipitated Opioid Withdrawal Under General Anaesthesia

Phase 4
Completed
Conditions
First Posted Date
2006-03-09
Last Posted Date
2006-11-14
Lead Sponsor
Vilnius University
Target Recruit Count
60
Registration Number
NCT00300794
Locations
🇱🇹

Vilnius University Emergency Hospital, Vilnius, Lithuania

Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease

Phase 4
Terminated
Conditions
Interventions
First Posted Date
2005-11-11
Last Posted Date
2009-03-13
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
3
Registration Number
NCT00252122
Locations
🇺🇸

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Administration of Ketamine to Prevent the Post-operative Pain

Phase 3
Completed
Conditions
First Posted Date
2005-09-21
Last Posted Date
2013-07-26
Lead Sponsor
Institut Bergonié
Target Recruit Count
230
Registration Number
NCT00210210
Locations
🇫🇷

Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest, Bordeaux, France

Ketamine and Postoperative Analgesia in Children

Phase 4
Conditions
First Posted Date
2005-09-20
Last Posted Date
2007-10-23
Lead Sponsor
Nantes University Hospital
Target Recruit Count
74
Registration Number
NCT00200564
Locations
🇫🇷

Nantes University Hospital, Nantes, France

Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids

First Posted Date
2005-09-20
Last Posted Date
2016-01-14
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
40
Registration Number
NCT00205712
Locations
🇺🇸

Washington University School of Medicine, Psychiatry Dept., St. Louis, Missouri, United States

The Use of Ketamine as Rescue Analgesia in the Recovery Room Following Opioid Administration. A Double-blind Randomised Trial in Postoperative Patients

Phase 4
Completed
Conditions
First Posted Date
2005-09-14
Last Posted Date
2016-01-15
Lead Sponsor
Bayside Health
Target Recruit Count
40
Registration Number
NCT00163969
Locations
🇦🇺

The Alfred Commercial Rd Prahran, Melbourne, Victoria, Australia

Ketamine Versus Fentanyl as an Adjunct to Propofol-Assisted Emergency Department Procedural Sedation

Not Applicable
Completed
Conditions
First Posted Date
2005-08-29
Last Posted Date
2007-06-14
Lead Sponsor
Queen's University
Target Recruit Count
124
Registration Number
NCT00137085
Locations
🇨🇦

Queen's University, Kingston, Ontario, Canada

Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy

Phase 4
Conditions
First Posted Date
2005-08-12
Last Posted Date
2007-03-12
Lead Sponsor
Hospices Civils de Lyon
Target Recruit Count
40
Registration Number
NCT00129597
Locations
🇫🇷

Centre Hospitalier Lyon Sud, Pierre bénite, France

© Copyright 2024. All Rights Reserved by MedPath